Korenberg Matthew E

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
13 Dec 24	PVLA Palvella Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	13.6	167,100	2.27 mm	167,100
23 Sep 24	LGND Ligand Pharmaceuticals	Common Stock	Sell	Dispose S	No	No	102.0541	201	20.51 k	50,777
23 Sep 24	LGND Ligand Pharmaceuticals	Common Stock	Sell	Dispose S	No	No	101.605	7,090	720.38 k	50,978
23 Sep 24	LGND Ligand Pharmaceuticals	Common Stock	Sell	Dispose S	No	No	100.0517	2,481	248.23 k	58,068
23 Sep 24	LGND Ligand Pharmaceuticals	Common Stock	Option exercise	Acquire M	No	No	52.84	9,377	495.48 k	60,549
23 Sep 24	LGND Ligand Pharmaceuticals	Common Stock	Option exercise	Acquire M	No	No	49.99	395	19.75 k	51,172
23 Sep 24	LGND Ligand Pharmaceuticals	Employee Stock Option Common Stock	Option exercise	Dispose M	No	No	52.84	9,377	495.48 k	42,436
23 Sep 24	LGND Ligand Pharmaceuticals	Employee Stock Option Common Stock	Option exercise	Dispose M	No	No	49.99	395	19.75 k	0
20 Sep 24	LGND Ligand Pharmaceuticals	Common Stock	Sell	Dispose S	No	No	104.1017	6,275	653.24 k	50,777
20 Sep 24	LGND Ligand Pharmaceuticals	Common Stock	Option exercise	Acquire M	No	No	49.99	4,982	249.05 k	57,052

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.